Southeast University Health System Custom Case Solution & Analysis

1. Evidence Brief: Southeast University Health System (SUHS)

Financial Metrics

Operating Margin: 2.4 percent for the most recent fiscal year, down from 4.1 percent three years prior.
Total Revenue: 1.8 billion dollars annually across the integrated health system.
Cost Position: Clinical delivery costs are 12 percent higher than the regional average for community-based competitors.
Payer Mix: Medicare and Medicaid represent 58 percent of total patient volume; private insurance reimbursement rates have flattened over the last 24 months.
Academic Subsidy: The clinical enterprise transfers 145 million dollars annually to support the School of Medicine and research initiatives.

Operational Facts

Capacity: Average bed occupancy sits at 84 percent, but surgical suite utilization peaks at only 62 percent due to scheduling conflicts between faculty research and clinical blocks.
Headcount: 12,500 total employees, including 1,100 faculty physicians.
Geography: Primary hub located in an urban center with three satellite community hospitals acquired within the last five years.
Governance: Dual-reporting structure where department chairs report to both the Dean of Medicine and the Health System CEO.

Stakeholder Positions

Dr. David Miller (CEO): Advocates for a unified clinical enterprise to reduce overhead and improve price competitiveness.
Dean of Medicine: Prioritizes NIH ranking and faculty research time; views clinical revenue primarily as a funding source for the academic mission.
Department Chairs: Maintain significant autonomy over hiring and clinical scheduling; resist centralized management of departmental funds.
Community Hospital Leads: Express frustration over high overhead allocations from the central academic hub that make their local pricing uncompetitive.

Information Gaps

Specific profitability margins for individual clinical departments (e.g., Cardiology vs. Pediatrics).
Exact debt covenants and the proximity to technical default if margins slide below 2 percent.
Detailed breakdown of the 12 percent cost disadvantage—specifically the split between labor, supply chain, and administrative overhead.

2. Strategic Analysis

Core Strategic Question

Can SUHS restructure its high-cost academic governance to survive a price-sensitive clinical market without compromising its research mission?

Structural Analysis

Supplier Power: High. Faculty physicians control the primary input (clinical expertise) and hold dual roles that shield them from traditional operational accountability.
Competitive Rivalry: Intense. Low-cost community providers are cherry-picking high-margin elective procedures, leaving SUHS with a disproportionate share of complex, low-reimbursement cases.
Value Chain Inconsistency: The current decentralized model creates redundant administrative layers in every department, inflating the cost floor.

Strategic Options

Option 1: The Unified Clinical Enterprise (UCE). Consolidate all clinical operations, billing, and scheduling under a single management structure.
Trade-off: Requires stripping department chairs of financial autonomy; risks faculty departures to private practice.
Resource Requirement: Significant investment in integrated IT and a new executive leadership layer.
Option 2: Academic Retrenchment. Scale back research subsidies and focus on high-margin clinical centers of excellence (Oncology, Cardiology).
Trade-off: Will result in a drop in national rankings and difficulty attracting top-tier residents.
Resource Requirement: Capital for specialized facility upgrades.
Option 3: Hub-and-Spoke Divestiture. Spin off community hospitals into a separate low-cost entity and maintain the academic center as a pure tertiary referral site.
Trade-off: Loses the primary care base that feeds the academic center.
Resource Requirement: Legal and financial restructuring costs.

Preliminary Recommendation

Implement Option 1 (Unified Clinical Enterprise). The current 12 percent cost disadvantage is largely structural, driven by departmental silos. SUHS cannot price its way out of this; it must reorganize. The academic mission is unsustainable if the clinical engine fails.

3. Implementation Roadmap

Critical Path

Month 1-3: Governance Reform. Establish a single Board of Directors for the clinical enterprise with authority over departmental budgets.
Month 4-6: Shared Service Integration. Centralize revenue cycle management, procurement, and HR to eliminate redundant departmental staff.
Month 7-12: Clinical Standardization. Implement system-wide scheduling for operating rooms to move utilization from 62 percent to 75 percent.
Month 13-18: Compensation Alignment. Transition faculty to a productivity-based pay model that rewards clinical efficiency alongside research output.

Key Constraints

Physician Resistance: Tenure-track faculty may view centralized scheduling as an infringement on academic freedom.
Legacy Systems: Merging disparate departmental billing systems will face technical and data-integrity hurdles.

Risk-Adjusted Implementation Strategy

The plan assumes a 15 percent attrition rate among senior faculty. To mitigate this, the transition will include a three-year glide path for departmental fund balances. Success depends on the CEO securing an explicit mandate from the University Trustees to override departmental objections.

4. Executive Review and BLUF

BLUF

SUHS will face a liquidity crisis within 36 months if it does not abandon its decentralized governance model. The 12 percent cost disadvantage against community peers is a direct result of departmental autonomy and redundant administrative structures. The health system must transition to a unified clinical enterprise immediately. This requires centralizing financial authority and standardizing clinical operations. Failure to act will result in the clinical enterprise becoming unable to subsidize the academic mission, leading to a forced downsizing of both.

Dangerous Assumption

The analysis assumes that the Dean of Medicine and Department Chairs will eventually align with the CEO once the financial reality is presented. In academic environments, prestige often outweighs profit. The risk of organizational paralysis during the governance transition is high and underestimated.

Unaddressed Risks

Payer Retaliation: If SUHS consolidates and attempts to use its market share to raise rates, private insurers may exclude the system from narrow networks, accelerating volume loss.
Philanthropic Decline: Alienating prominent department chairs may lead to a significant drop in donor contributions, which are often tied to specific faculty leaders rather than the institution.

Unconsidered Alternative

The team did not evaluate a full merger with a larger national non-profit health system. While this would sacrifice local autonomy, it would provide the immediate scale and capital required to offset the current cost disadvantage without the internal trauma of a five-year restructuring.